Precigen, Inc. Share Price
NASDAQ: PGEN | Mid CapPrecigen, Inc. Stock Performance
Precigen, Inc. Share Price Today
As of 10 October 2026, Precigen, Inc.'s share price is $7.82. The stock opened at $7.59, compared to its previous close of $7.59. During today's trading session, Precigen, Inc.'s share price traded between $7.48 and $7.83, with an average price of $7.65. Over the past 52 weeks, the stock has recorded a high of $8.98 and a low of $3.00. In terms of performance, Precigen, Inc.'s share price has risen by 87.86% over the last six months and is up 88.31% on a year-on-year basis.
Precigen, Inc. Share Price Chart
Precigen, Inc. Quarterly Profit & Loss
All figures in USD
Precigen, Inc. Annual Profit & Loss
All figures in USD
About Precigen, Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Precigen, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $8.53 | $7.81 | -8.97% |
Sep 2026 | $6.87 | $8.58 | +19.50% |
Aug 2026 | $6.22 | $7.18 | +14.51% |
Jul 2026 | $5.67 | $6.27 | +10.00% |
Jun 2026 | $4.30 | $5.70 | +31.34% |
May 2026 | $4.14 | $4.34 | +4.33% |
Apr 2026 | $3.80 | $4.16 | +7.77% |
Mar 2026 | $3.69 | $3.86 | +1.71% |
Feb 2026 | $4.42 | $3.79 | -15.67% |
Jan 2026 | $4.18 | $4.50 | +7.91% |
Dec 2025 | $3.77 | $4.17 | +9.16% |
Nov 2025 | $4.22 | $3.82 | -7.95% |